U.S. pharma huge copyright scrapped two experimental weight loss tablets past yr—a the moment-daily capsule, lotiglipron, resulting from elevated liver enzymes and a 2 times-each day capsule, danuglipron, because of potent Negative effects—but CEO Albert Bourla has claimed the compan